Saturday, December 29, 2007

Elixir of life

So while standing tall provides the Indian pharmaceutical industry with the required visibility, it’s the vibrancy that boosts its growth, a fact that has been instrumental in its huge success across the globe. Now with a more than two years of existence under the product patent regime (introduced in January 2005), a lot of things seem to have changed. A shift in focus for growth in the marketplace (away from mature markets to emerging ones and from primary care classes to biotech and specialist-driven therapies) has been the order of the day globally, with India being no exception. One of the most evident examples of this is the shift from US market towards Europe. Indian pharma majors, who made their fortunes in the US during the last vestiges of the previous century, now for the last couple of years, seem busy focusing on other markets, particularly Europe.
For the first time in its history, Ranbaxy reported a 78% year-on-year jump in European sales at $93 million for the quarter ended March 2007, while its revenues from the US grew by a miniscule 3% to $86 million. It was not the only Indian pharma major. 50% of Wockhardt’s revenue was from Europe and even Dr Reddy’s Labs (whose maximum revenues were still from US), witnessed a significant rise in sales from Europe. Its revenues from European generics (including betapharm) stood at $223 million, as against $56 million in FY ’06.

For Complete IIPM Article, Click here

Source: IIPM Editorial, 2006

An IIPM and Management Guru Prof. Arindam Chaudhuri's Initiative

Thursday, December 13, 2007

The rich West Bank & barren Gaza

The US never tires of talking about democracy and the methodology to be adopted to inculcate the tenets of freedom in the Muslim mind. When it comes to action, all the US does is to either bomb the country out of shape (as in Iraq) or encourage an undemocratic divide in the nation, leading to the overthrow of legitimately elected government (as in Palestine). The US and its biggest stooge Israel have managed to push the popular Hamas faction to Gaza and installed another Western poodle, Mahmoud Abbas in West Bank, as the so-called “moderate” leader of the Palestinian Authority. America, Israel and the EU are showering billions of dollars on Abbas to help him marginalize the Palestinian struggle and embarrass the other leaders. What are the credentials of Abbas, which make him the blue-eyed boy of the West? "Abbas came into limelight with his 600 page book on the Oslo peace accord. Interestingly, he wrote his book without once mentioning the word 'occupation', referred to Israeli 'redeployment' rather than 'withdrawal', "shared a London-based noted columnist Robert Fisk, while talking to B&E. "Yes, Abbas is a nice boy, their kind of guy, because he wears a tie and goes to the White House and says all the right things,” adds Fisk.
For Complete IIPM Article, Click here

Source: IIPM Editorial, 2006

An IIPM and Management Guru Prof. Arindam Chaudhuri's Initiative

Wednesday, December 05, 2007

A politician’s gift

The British perhaps had seen it a long time back and were prudent enough to exit in time. It is rather intriguing that even sixty years after their exit, the problem of sectarian violence, sometimes as communal clashes or caste violence and oft en on ethnic and class grounds, torments India. As if the external threats from our noble neighbours was not enough, these oft en avoidable internal conflicts have the potential to nullify all that independent India has achieved in six decades.
For Complete IIPM Article, Click here

Source: IIPM Editorial, 2006

An IIPM and Management Guru Prof. Arindam Chaudhuri's Initiative